Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,696 | -26,262 | -22,241 | -18,730 | -10,860 |
| Depreciation Amortization | 60 | 266 | 201 | 135 | 68 |
| Accounts payable and accrued liabilities | -454 | -1,412 | -1,528 | 2,266 | -263 |
| Other Working Capital | -407 | -5,130 | -4,643 | -968 | 1,064 |
| Other Operating Activity | 20,899 | 5,718 | 4,965 | 830 | 1,955 |
| Operating Cash Flow | $-7,598 | $-26,820 | $-23,246 | $-16,467 | $-8,036 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -6,426 | -6,426 | -6,426 | -2,198 |
| Common Stock Issued | 1,696 | 10,685 | 5,060 | 5,047 | 1,477 |
| Other Financing Activity | 0 | 0 | 1,858 | 1,858 | 0 |
| Financing Cash Flow | $1,696 | $4,259 | $492 | $479 | $-721 |
| Beginning Cash Position | 8,150 | 30,711 | 30,711 | 30,711 | 30,711 |
| End Cash Position | 2,248 | 8,150 | 7,957 | 14,723 | 21,954 |
| Net Cash Flow | $-5,902 | $-22,561 | $-22,754 | $-15,988 | $-8,757 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,598 | -26,820 | -23,246 | -16,467 | -8,036 |
| Free Cash Flow | -7,598 | -26,820 | -23,246 | -16,467 | -8,036 |